Brain Check: p-Tau217 (Phosphorylated tau 217), NfL (neurofilament light), GFAP (glial fibrillary acidic protein) Note: These tests are not intended to provide a diagnosis, but to detect early signs leading to Alzheimer’s dementia to provide the opportunity for preventative strategies.Â
APOE: APOE Alzheimer’s Risk
Biotoxin Inflammatory/Genetic: TGF-Beta 1, MSH (Melanocyte Stimulating Hormone), MMP-9, VEGF, HLA DR1/3/4/5, DQ
Galectin-3: This test measures the level of Galectin-3, a protein, in the blood
Glial Fibrillary Acid Protein: This test is used for measurement of glial fibrillary acidic protein (GFAP) in EDTA plasma
LucentAD: The Quanterix LucentAD tests aids in the evaluation of patients experiencing cognitive symptoms consistent with early signs of Alzheimer’s disease
Neurofilament Light Chain, Plasma: This test is used for the measurement of the level of Neurofilament Light Chain in plasma
pTau-217, Plasma: This test is used to aid in the biological identification of Alzheimer’s disease by measuring phosphorylated tau 217, which has been shown in the literature to be a surrogate of amyloid pathology. Additionally, pTau-217 can be used for monitoring patients on newly approved anti-amyloid therapy
Stress + Hormone Profile: The Stress & Hormone Profile measures salivary levels of key hormones – Estradiol, Progesterone, Testosterone, DHEAS, Cortisol– with the addition of daytime levels of Melatonin and Secretory IgA, key indicators of immune and stress imbalance or dysfunction.
$929.00
$139.00
$388.00
$90.00
$259.00
$492.00
$252.00
$253.00
$346.00